Omnicell 

$39.99
14
+$2.16+5.71% Monday 19:59

統計

當日最高
40.22
當日最低
38.39
52週高點
55
52週低點
26.85
成交量
922,263
平均成交量
-
市值
1.82B
本益比
88.61
股息殖利率
-
股息
-

即將到來

財報

30Jul預期
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
下一步
0.2
0.34
0.47
0.6
預期EPS
0.4675
實際EPS
不適用

財務

0.17%利潤率
有盈利
2020
2021
2022
2023
2024
2025
2.37B營收
4.1M淨利

分析師評級

61.67平均目標價
最高預估為 70.00。
來自過去6個月內的 3 則評分。這不是投資建議。
買入
100%
持有
0%
賣出
0%

其他人也在關注

此清單是根據在 Stock Events 上追蹤 OMCL 的使用者自選建立的。這不是投資建議。

競爭對手

此清單為基於近期市場事件的分析。並非投資建議。

關於

Omnicell, Inc., founded in 1992 and headquartered in Mountain View, California (initially operating as Omnicell Technologies, Inc. until its name change in 2001), delivers advanced medication management technologies and patient adherence solutions. The company serves healthcare systems and pharmacies both domestically within the United States and globally. Its extensive portfolio of offerings includes: Clinical Workflow Automation: Omnicell provides automated solutions designed to streamline clinician tasks in patient care environments. This encompasses the XT Series automated dispensing units for medications and supplies across nursing units, clinical areas, and surgical suites. They also offer interface software to ensure smooth integration between their products and a healthcare facility's existing information systems, alongside robotic systems for automated storage and retrieval of packaged medications. Central Pharmacy Optimization: For the central pharmacy, Omnicell offers sophisticated automation, including automated storage and retrieval platforms like the XR2 Automated Central Pharmacy System. This segment also features robotic systems and workflow management tools for IV compounding, comprehensive inventory management software, and systems for controlled substance oversight. Single-Dose Packaging for Adherence: The company develops automated technologies for filling and labeling patient-specific, single-dose medication blister packaging according to prescriptions. This includes both fully and semi-automated equipment for institutional pharmacies to ensure precise packaging, along with blister card packaging and supplies aimed at improving medication adherence, particularly in non-acute care settings. Digital Patient Engagement: Omnicell further provides EnlivenHealth Patient Engagement, a web-based platform offering various tools to interact with patients.
Show more...
執行長
Mr. Randall A. Lipps
員工
3620
國家
美國
ISIN
US68213N1090

上市

0 Comments

分享你的想法

FAQ

Omnicell 今天的股價是多少?
OMCL 目前價格為 $39.99 USD,過去 24 小時上漲了 +5.71%。在圖表上更密切關注 Omnicell 股價表現。
Omnicell 的股票代號是什麼?
根據交易所不同,股票代號可能會有所差異。例如,在 交易所,Omnicell 的股票以代號 OMCL 進行交易。
Omnicell 的股價在上漲嗎?
OMCL 股票較上週下跌 -1.72%,本月下跌 -7.26%,但在過去一年中,Omnicell 上漲了 +36.86%。
Omnicell 的市值是多少?
今天 Omnicell 的市值為 1.82B
Omnicell 下一次財報日期是什麼時候?
Omnicell 將於 July 30, 2026 公布下一次財報。
Omnicell 上一季度的財報如何?
OMCL 上一季度的財報為每股 0.55 USD,預估為 0.33 USD,帶來 +66.04% 的驚喜。下一季度的預估財報為每股 不適用 USD。
Omnicell 去年的營收是多少?
Omnicell 去年的營收為 2.37BUSD。
Omnicell 去年的淨利是多少?
OMCL 去年的淨收益為 4.1MUSD。
Omnicell 有多少名員工?
截至 June 16, 2026,公司共有 3,620 名員工。
Omnicell 位於哪個產業?
Omnicell從事於Health & Wellness產業。
Omnicell 何時完成拆股?
Omnicell 最近沒有進行任何拆股。
Omnicell 的總部在哪裡?
Omnicell 的總部位於 美國 的 Fort Worth。